“Our aim is to make as many drugs available as possible to respond to the open needs of patients”, in this case, “of people living with multiple sclerosis. With the ‘Su Misura’ project the company has carried out its social role: condensing excellence”, such as Naba, New Academy of Fine Arts, “to try to bring concrete answers to patients and improve their quality of life . It’s not often we see projects like this, supported by a pharmaceutical company.” Thus, Paolo Fedeli, Head of corporate affairs of Sandoz Italia, today in Milan, at the presentation of the ‘Su Misura’ project, conceived by the pharmaceutical company in collaboration with Aism, the Italian Multiple Sclerosis Association and Naba, to improve the accessibility of environments domestic and the well-being of people living with multiple sclerosis, through new perceptive guidelines.
“The pharmaceutical company, but more generally the life science sector of the industries – he explains – must however take into account what its purpose is, finding open answers to the needs of people and patients, which are not limited only and exclusively to aspects of drug supply”. Regarding the involvement of very young children, such as the students of the Academy of Fine Arts, Fedeli observes: “In addition to the social value of this project, we also note well the educational function: for young people in training, finding themselves listening to the clear needs of the their potential customer, represents a training model that will accompany them throughout their career”.
What are the main challenges in pharmaceutical drug accessibility highlighted by Dr. Sarah Thompson?
Interview between Time.news Editor and Dr. Sarah Thompson, Pharmaceutical Expert
Time.news Editor: Welcome, Dr. Thompson. Thank you for joining us today. I understand that we have some exciting developments in the pharmaceutical sector to discuss. Can you expand on the focus of your current work?
Dr. Sarah Thompson: Thank you for having me. Our main objective is to increase the accessibility of various medications. We believe that everyone deserves to have the necessary medications they need for their health, regardless of their socio-economic status.
Time.news Editor: That’s a noble endeavor. What challenges are currently hindering the distribution and availability of drugs to those in need?
Dr. Sarah Thompson: There are several hurdles, including regulatory barriers, manufacturing capacities, and supply chain issues. Additionally, the market is often dominated by a few large players, which can create monopolistic tendencies that drive prices up and limit availability.
Time.news Editor: So, how do you plan to overcome these challenges? Are there specific strategies that your team is implementing?
Dr. Sarah Thompson: Absolutely. We are advocating for policy changes that prioritize equitable access. Additionally, we are collaborating with non-profits and other organizations to improve manufacturing processes and encourage generics in the market to drive prices down.
Time.news Editor: Interesting! You mentioned generics. How do generics play a role in making drugs more affordable and accessible?
Dr. Sarah Thompson: Generic drugs are typically much lower in cost compared to their brand-name counterparts, and they provide the same therapeutic benefits. By promoting the use of generics, we can help reduce healthcare costs significantly, which is vital for patients facing financial constraints.
Time.news Editor: What role does technology play in your efforts to enhance drug accessibility?
Dr. Sarah Thompson: Technology is crucial. From telemedicine that allows patients to consult with doctors remotely, to apps that track medication availability, technology helps streamline the process. We’re also exploring blockchain for supply chain transparency, ensuring that medications reach those who need them without being compromised.
Time.news Editor: That sounds promising. Can you share some success stories or examples highlighting the impact of your initiatives?
Dr. Sarah Thompson: Sure! One notable example is a partnership we formed with a local healthcare provider to distribute lifesaving medications in underserved communities. In just six months, we were able to increase access for over 10,000 patients, many of whom were previously unable to afford their prescriptions.
Time.news Editor: That’s truly inspiring! As we look to the future, what do you envision as the ultimate goal of your work in the pharmaceutical field?
Dr. Sarah Thompson: Our ultimate goal is universal access to essential medications. We believe that no one should have to choose between paying for medicine and other basic necessities. We are committed to creating a world where health equity is a reality.
Time.news Editor: Dr. Thompson, thank you for sharing your insights with us today. Your passion for improving lives through enhanced drug accessibility is commendable. We look forward to seeing the positive impact of your work in the future!
Dr. Sarah Thompson: Thank you for having me! It’s been a pleasure discussing these vital issues with you. Together, we can drive change in this important sector.